Mikhail Eydelman
Compliance Officer at VAXCYTE, INC.
Net worth: 2 M $ as of 30/04/2024
Mikhail Eydelman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VAXCYTE, INC. | Compliance Officer | 01/04/2022 | - |
| General Counsel | 01/04/2022 | - | |
| Corporate Secretary | 01/03/2023 | - |
Career history of Mikhail Eydelman
Former positions of Mikhail Eydelman
| Companies | Position | Start | End |
|---|---|---|---|
| SAGENT PHARMACEUTICALS INC | General Counsel | 01/01/2017 | 01/04/2022 |
| Corporate Secretary | 01/01/2017 | 01/04/2022 |
Training of Mikhail Eydelman
| Brandeis University | Undergraduate Degree |
| New York University School of Law | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Secretary | 2 |
| General Counsel | 2 |
| Compliance Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sagent Pharmaceuticals, Inc.
 Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Stock Market
- Insiders
- Mikhail Eydelman
- Experience
